首页> 美国卫生研究院文献>The CRISPR Journal >An Engineered Cas-Transposon System for Programmable and Site-Directed DNA Transpositions
【2h】

An Engineered Cas-Transposon System for Programmable and Site-Directed DNA Transpositions

机译:工程Cas-Transposon系统用于可编程和定点DNA转座

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Efficient site-directed insertion of heterologous DNA into a genome remains an outstanding challenge. Recombinases that can integrate kilobase-sized DNA constructs are difficult to reprogram to user-defined loci, while genomic insertion using CRISPR-Cas methods relies on inefficient host DNA repair machinery. Here, we describe a Cas-Transposon (CasTn) system for genomic insertions that uses a Himar1 transposase fused to a catalytically dead dCas9 nuclease to mediate programmable, site-directed transposition. Using cell-free assays, we demonstrated that the Himar–dCas9 fusion protein increased the frequency of transposon insertion at a single targeted TA dinucleotide by >300-fold compared to a random transposase, and that site-directed transposition is dependent on target choice while robust to log-fold variations in protein and DNA concentrations. We also showed that Himar–dCas9 mediates directed transposition into plasmids in . This work highlights CasTn as a new modality for host-independent, programmable, site-directed DNA insertions.
机译:有效地将异源DNA定点插入基因组仍然是一项艰巨的挑战。可以整合千碱基大小的DNA构建体的重组酶很难重编程为用户定义的基因座,而使用CRISPR-Cas方法进行基因组插入则依赖于效率低下的宿主DNA修复机制。在这里,我们描述了一个用于基因组插入的Cas-Transposon(CasTn)系统,该系统使用与催化死dCas9核酸酶融合的Himar1转座酶来介导可编程的定点转座。使用无细胞试验,我们证明了与随机转座酶相比,Himar–dCas9融合蛋白使单个靶向TA二核苷酸的转座子插入频率增加了300倍以上,并且定点转座取决于靶选择,而对蛋白质和DNA浓度的对数变化具有鲁棒性。我们还表明,Himar–dCas9介导了定向转座入质粒。这项工作强调了CasTn是一种独立于宿主的,可编程的,定点的DNA插入的新形式。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号